SOPHiA GENETICS (SOPH) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
SOPHiA GENETICS SA has reported its unaudited interim condensed consolidated financial results, indicating a gross profit increase for the three and six months ended June 30, 2024, compared to the same periods in 2023. However, the company is also facing significant research and development as well as general and administrative costs, impacting their overall financial position.
For further insights into SOPH stock, check out TipRanks’ Stock Analysis page.
